Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on May 7, 2025
AsstrA at Transport Logistic 2025 in Munich
EIN Presswire
·
May 7, 2025
AsstrA-Associated Traffic AG is excited to announce its participation in Transport Logistic 2025. SWITZERLAND, May 7, 2025 /EINPresswire.com/ -- AsstrA-Associated Traffic AG is excited to announce its participation in Transport Logistic 2025, the world …
BrandMail Wins the Spring 2025 Leader Award in Email Signature Software from SourceForge
EIN Presswire
·
May 7, 2025
BrandQuantum announces that Sourceforge has named it a Spring 2025 Leader in the Email Signature Software category. WICHITA, KS, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- BrandQuantum, developer of BrandMail, is proud to announce that it has been …
Riad Tizwa to Become Morocco’s First Verified Bamboo Badge Hotel with the Tuu Eco Stay Awards
EIN Presswire
·
May 7, 2025
Riad Tizwa, one of Morocco’s most environmentally conscious hotels, is proud to announce its official participation in the Tuu Eco Stay Awards program. MARRAKECH, MOROCCO, May 7, 2025 /EINPresswire.com/ -- Riad Tizwa, one of Morocco’s most …
Okeanis Eco Tankers Corp. – Files Two Registration Statements on Form F-3
GlobeNewswire
·
May 7, 2025
ATHENS, Greece, May 07, 2025 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE:ECO / OSE:OET), announced today that it has filed with the U.S. Securities and Exchange Commission (the “SEC”) a shelf registration statement on Form …
leagend’s Battery Testers with Advanced Thermal-Printing Solutions Set a New Standard in Precision Diagnostics
EIN Presswire
·
May 7, 2025
leagend today announced the launch of three new additions to its industry-leading battery-tester portfolio: leagend BA4000, leagend BA1000 and leagend BA2000 SHENZHEN, GUANGDONG, CHINA, May 7, 2025 /EINPresswire.com/ -- leagend today announced the …
Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
GlobeNewswire
·
May 7, 2025
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to $12.4 …
Fire Retardant Fabrics Market to Reach USD 7,120 Million by 2035, Driven by Safety Demands and Tech Advancements
EIN Presswire
·
May 7, 2025
The UK's fire-retardant textiles market is growing steadily at a 6.0% CAGR from 2025 to 2035, driven mainly by rising use in the oil and gas sector. NEWARK, DE, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- The fire retardant fabrics market is …
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025
GlobeNewswire
·
May 7, 2025
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 Mont-Saint-Guibert, Belgium – Wednesday May 7, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough …
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2025 le 14 Mai 2025
GlobeNewswire
·
May 7, 2025
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2025 le 14 Mai 2025 Mont-Saint-Guibert, Belgique – 7 mai 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie …
Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
GlobeNewswire
·
May 7, 2025
MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …
Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update
GlobeNewswire
·
May 7, 2025
- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial ongoing with clinical data update at 2025 ASCO® Annual Meeting - Based on the Company’s current operating plan, existing cash, cash equivalents and marketable securities …
GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
GlobeNewswire
·
May 7, 2025
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 7, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires
GlobeNewswire
·
May 7, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
GlobeNewswire
·
May 7, 2025
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …
Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 7, 2025
CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …
MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance
GlobeNewswire
·
May 7, 2025
ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and portfolio strategy to be announced mid …
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
GlobeNewswire
·
May 7, 2025
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …
Century Aluminum Company Reports First Quarter 2025 Results
GlobeNewswire
·
May 7, 2025
CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its first quarter 2025 results. First Quarter 2025 Financial Results $MM (except shipments and per share data) Q1 2025 Q4 2024 Aluminum shipments ( …
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
Interim Data from Low Dose Cohort in MyPEAKTM-1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History and Seroprevalence Study Highlights …